Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
J Clin Invest. 1993 Apr;91(4):1399-404. doi: 10.1172/JCI116343.
We have identified a novel autoantibody reactive with all three classes of RNA polymerases, well-characterized nuclear enzymes, in sera from patients with systemic sclerosis (SSc). After incubation with [35S]methionine-labeled HeLa cell extracts, 14 of 275 SSc sera immunoprecipitated 12 or 14 proteins with similar molecular weights as those of several subunit proteins of eukaryotic RNA polymerases I, II, and III. Purified IgG from these two types of sera inhibited RNA transcription catalyzed by RNA polymerases I, II, and III in vitro. Immunoblot analysis using RNA polymerase-enriched fraction showed that the majority of these sera reacted with 42- or 25-kD protein. Anti-RNA polymerase antibody was highly specific to SSc, especially to diffuse cutaneous SSc. Clinical features associated with this antibody included a high frequency of heart and kidney involvement and a poor survival rate at 5 yr after first visit. These findings indicate that the autoantibody to three classes of RNA polymerases is a new marker for a unique subset of diffuse cutaneous SSc.
我们在系统性硬化症(SSc)患者的血清中鉴定出一种新型自身抗体,它能与所有三类RNA聚合酶(这是一类特征明确的核酶)发生反应。用[35S]甲硫氨酸标记的HeLa细胞提取物孵育后,275份SSc血清中有14份免疫沉淀出了12种或14种蛋白质,其分子量与真核RNA聚合酶I、II和III的几种亚基蛋白相似。从这两种血清中纯化得到的IgG在体外可抑制RNA聚合酶I、II和III催化的RNA转录。使用富含RNA聚合酶的组分进行免疫印迹分析表明,这些血清中的大多数与42-kD或25-kD蛋白发生反应。抗RNA聚合酶抗体对SSc具有高度特异性,尤其是对弥漫性皮肤型SSc。与该抗体相关的临床特征包括心脏和肾脏受累的频率较高,以及首次就诊后5年的生存率较低。这些发现表明,针对三类RNA聚合酶的自身抗体是弥漫性皮肤型SSc一个独特亚群的新标志物。